Provention Bio, Inc. Quarterly Operating Income (Loss) in USD from Q4 2016 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Provention Bio, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q4 2016 to Q4 2022.
  • Provention Bio, Inc. Operating Income (Loss) for the quarter ending December 31, 2022 was -$40.2M, a 55.3% decline year-over-year.
  • Provention Bio, Inc. Operating Income (Loss) for the twelve months ending December 31, 2022 was -$128M, a 10.9% decline year-over-year.
  • Provention Bio, Inc. annual Operating Income (Loss) for 2022 was -$128M, a 10.9% decline from 2021.
  • Provention Bio, Inc. annual Operating Income (Loss) for 2021 was -$116M, a 15.9% decline from 2020.
  • Provention Bio, Inc. annual Operating Income (Loss) for 2020 was -$99.7M, a 125% decline from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2022 -$128M -$40.2M -$14.3M -55.3% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-29
Q3 2022 -$114M -$29.1M -$2M -7.39% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-03
Q2 2022 -$112M -$29.8M +$340K +1.13% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-04
Q1 2022 -$112M -$29.1M +$3.39M +10.4% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-05
Q4 2021 -$116M -$25.9M +$6.76M +20.7% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-29
Q3 2021 -$122M -$27.1M +$4.33M +13.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 -$127M -$30.2M -$7.38M -32.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 -$119M -$32.5M -$19.6M -152% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 -$99.7M -$32.6M -$21.7M -200% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-29
Q3 2020 -$78M -$31.4M -$21.4M -215% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$56.5M -$22.8M -$10.5M -86% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 -$46M -$12.9M -$1.61M -14.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 -$44.4M -$10.9M -$4.68M -75.5% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-24
Q3 2019 -$39.7M -$9.97M -$4.56M -84.3% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 -$35.1M -$12.3M -$2.09M -20.6% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 -$33M -$11.3M -$6.22M -124% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 -$26.8M -$6.2M Oct 1, 2018 Dec 31, 2018 10-K 2021-02-25
Q3 2018 -$5.41M -$4.04M -294% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-05
Q2 2018 -$10.2M -$6.18M -155% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 -$5.04M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q3 2017 -$1.38M Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 -$3.99M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-13
Q4 2016 -$165K Oct 4, 2016 Dec 31, 2016 10-K 2019-03-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.